Login
Home
Charts
Search
Watchlist
Products
All IPOs

Ravelcare Ltd

E-Commerce/App based AggregatorIPOSME
₹130 - 130
₹130 - 130

Our Company operates through a digital first distribution model in the beauty and personal care segment ("BPC") offering a range of haircare, skincare, and bodycare products. Our current operations are built around a direct-to-consumer (D2C) approach, supported by e-commerce and data-driven product development processes. Our products are sold through multiple channels including our website, major online marketplaces such as Amazon, Flipkart and Myntra and quick commerce platform i.e. Blinkit. The percentage of repeat orders was 36.86%, 32.55%, 22.12% and 16.81% during the period ended September 30, 2025 and financial years ended March 31, 2025, March 31, 2024 and March 31, 2023 respectively. Our revenue from operations for the period ended September 30, 2025 and Financial Year ended March 31, 2025, March 31, 2024 and March 31, 2023 was Rs. 1,439.76 lakhs, Rs. 2,497.89 lakhs, Rs. 2,208.78 lakhs and Rs. 349.36 lakhs respectively.

Lot1,000Min Invest₹2,60,000Face Value₹10Issue Size₹24 CrFresh Issue₹24 CrListing Price₹201CMP₹113

Timeline

1 Dec
Bidding opens
3 Dec
Bidding closes
4 Dec
Allotment
5 Dec
Refund & demat credit
8 Dec
Listing

Subscription

Subscription opens once dates are announced

Reports

Offer Details

Terms

Issue Size₹24 Cr0.19 Cr shares
Fresh Issue₹24 Cr
Face Value₹10
Lot Size1,000 shares
ReservationQIB 49.77% · NII 15% · RETAIL 35.23%

Application Sizes

Retail2,60,0001-1 lots
sNII2,60,000from 2 lots
bNII10,40,000from 8 lots

Managers & Registrar

Lead ManagerMarwadi Chandrana Intermediaries Brokers Pvt Ltd
RegistrarKFin Technologies Ltd

Ownership & Proceeds

Shareholding

CategoryPre IPOPost IPOPromoter Group99.96%72.93%Public0.04%27.07%

Objects of the Issue

  1. Marketing and advertisement expenses toward enhancing the awareness and visibility of its brand
  2. Setting up a new manufacturing facility at Mauje-Peth in Amravati ("Proposed facility")
  3. Investment into research and product development
  4. General corporate purposes

Financials

Profit & Loss

Financial YearFY22FY23FY24FY25FY26
RevenueCr13222527
Operating ProfitCr01777
OPM%-27.614.630.427.326.2
PBTCr01777
PATCr01555
EPS-1110109

Balance Sheet

Financial YearFY22FY23FY24FY25FY26
Equity CapitalCr0005-
ReservesCr0055-
BorrowingsCr0000-
Total AssetsCr02913-

Cash Flow

Financial YearFY22FY23FY24FY25FY26
Operating Cash FlowCr016-1-17
Investing Cash FlowCr00-71-4
Financing Cash FlowCr000022
Net Cash FlowCr01-110

Strengths & Risks

Strengths · as stated in the DRHP
  • Diversified customer base having a wide geographic presence.
  • Digital Distribution Channel.
  • Strong Customer relationships.
  • Product Innovations.
  • Consistent track record of growth and financial performance.
  • Strong technology backbone supported by a dedicated team.
Strategies · as stated in the DRHP
  • Personalization at Scale.
  • Direct-to-Consumer (D2C) Model.
  • Digital Marketing and Engagement.
  • Strong Customer Relationships.
  • Vertical Integration for Improved Operational Control.
  • Wider market access through E-commerce and quick commerce.
Show all 9 strategies
Risks · as stated in the DRHP
  • There are certain pending legal proceeding involving Director of the Company. Any adverse outcome on such proceeding may affect its business, financial condition and reputation.
  • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect the company business, reputation and results of operations.
  • The Company has faced losses in the past.
  • The Company is dependent on few suppliers for purchase of products. Loss of any of these large suppliers may affect its business operations.
  • The company does not own its Registered Office from where its operations are being conducted and have been taken on lease. Any difficulty in seeking renewal or extension of such lease terms may cause disruption in its operations.
  • There have been some instances of delay in filing of statutory and regulatory dues in the past with the various government authorities.
Show all 85 risks